[에트노바테라퓨틱스] 국가신약개발사업단 '2022년도 제3차 국가신약개발사업' 연구과제 예비선정
https://www.dailymedi.com/news/news_view.php?wr_id=888381
https://blog.naver.com/ipsventures/222879516862
서울 서초구 서초중앙로8길 7, 3층 (서초동, 더에스엠 빌딩)
Tel : 070-4295-6907 E-mail : mail@ipsventures.com Fax : +82-2-6434-8036
Copyright © IPSVentures - 아이피에스벤처스. All Rights Reserved.
https://www.dailymedi.com/news/news_view.php?wr_id=888381
https://blog.naver.com/ipsventures/222879516862